Drug intelligence / Profile preview

oxycodone + acetaminophen

Development stage
Approved
Lead developer
Endo International
Modality
Small Molecules
Administration
Oral
01

Overview

Oxycodone + acetaminophen is a fixed-dose combination oral analgesic used to relieve moderate to severe pain when opioid treatment is necessary and other pain medicines are inadequate or not tolerated. Oxycodone is an opioid analgesic that acts on the central nervous system by binding to opioid receptors, reducing the transmission of pain signals in the brain and spinal cord. Acetaminophen is a non-opioid analgesic and antipyretic that works primarily by inhibiting prostaglandin synthesis in the central nervous system, thereby enhancing the effects of oxycodone. The combination provides synergistic pain relief but carries risks such as dependence, addiction (primarily due to oxycodone), respiratory depression, and potential liver toxicity at high doses or with prolonged use due to acetaminophen[1][3][4][5]. It is available only by prescription.

Brand names
EndocetMagnacetNarvoxPercocetPerloxxPrimalevRoxicetRoxiloxTyloxXartemix XRXoloxoxyCODONE/ACET (Canada)Rivacocet (Canada)Teva-Oxycocet (Canada)
Other names
oxycodone and acetaminophen
02

Targets

MOR (Mu opioid receptor)KOR (Kappa opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)DOR (Opioid Receptor Delta 1)

Beyond the preview

Go deeper on oxycodone + acetaminophen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxycodone + acetaminophen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call